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Abstract
Klinefelter Syndrome is a genetic disorder caused by the presence of supernumerary sex 
chromosomes. An additional X chromosome(s) and hypogonadism are the two defining 
features of Klinefelter syndrome (Groth, 2013). The excess of genes from the additional X 
chromosome drives the pathogenesis of the disease and distinguishing features of the 
affected individuals. Genotypic variants exist within the affected population, leading to 
differences in phenotype and severity of symptoms (Bonomi, 2017). The increase in the 
prevalence of prenatal testing has led to the earlier recognition of fetal chromosomal 
abnormalities. Early detection of Klinefelter syndrome through noninvasive prenatal testing 
is an extraordinary medical tool, giving the family much need information and allowing for 
early intervention, ensuring the best outcome for the child (Groth, 2013).  This case report 
shows a patient that will greatly benefit from the early diagnosis of a genetic syndrome to 
implement early and timely interventions upon delivery and then later on in the child’s 
developing years. 
Case Report
A male infant was born at 37 weeks gestation. His mother was a 29-year-old, gravida 4 para 3 
woman. During her pregnancy she was curious as to the gender of the fetus and requested a 
non-invasive prenatal test (NIPT) rather than fetal ultrasound. The NIPT returned with a 
karyotype of XXY. The male infant was born vaginally with a birth weight of 2670 grams. 
Apgar scores were 8 and 9 at one and five minutes respectively. He was admitted to the 
newborn intensive care unit secondary to respiratory distress. He had no obvious 
dysmorphic features. He had normal appearing male genitalia with testes descended 
bilaterally. Fluorescent in situ hybridization and blood chromosomes confirmed an XXY 
karyotype. He was discharged from the newborn intensive care unit with follow up by 
genetic counselors and close monitoring for developmental delays.
Figure 1, Non-disjuntional of Klinefelter producing gametogenesis. (Kanakis, 
2018)
Table 1. Klinefelter Syndrome’s Manifestations
- Modified table from Groth et al., 2013 publication on Clinical Features of KS
Feature Tentative Frequency
Infertility > 95%
Increased Gonadotrophin Hormones > 95%
Decreased Testicular Volume > 95%
Azoospermia > 95%
Learning Disability > 75%
Testosterone Deficiency 60-85%






Decreased Bone Density 5-40%
Type II Diabetes Mellitus 10-40%
Cryptorchidism 37%
Decreased Penile Size 10-25%
Psychiatric Conditions 25%




Table 1, KS Manifestations and general frequency of presentation in confirmed cases (Groth, 2013).
Genetics
Supernumerary X chromosomal aneuploidy leads to the majority (80%) of Klinefelter 
individuals possessing the karyotypic pattern 47XXY (Bonomi, 2017). This arises due to 
nondisjunction occurring in gametogenesis. Nondisjunction arises equally from paternal and 
maternal origins. The remaining minority of genotypes includes, but is not limited to, 
47,XXY/46,XY mosaicism, 48,XXXY/47,XXY, and 48,XXXY. arises due to the non-disjunction 
event of the X chromosome occurring in the early mitotic stages of the developing 46,XY 
zygote or through a X chromosome being lost due to anaphase lag in the mitotic 
development of a 47,XXY zygote (Bonomi, 2017). 
Nondisjunction occurs 
during meiosis of the 
respective gametes:
• Meiosis I or II of 
maternal Oocyte
• Meiosis I of paternal 
Spermatocyte
Genotypic factors driving 
phenotype and variance:
• Gene dosage by 
additional X
• CAG repeat 
polymorphisms
• Pseudo autosomal 
regions (PARs) 
expressed
• Gene’s copy number 
variants (CNVs)
Non-Invasive Prenatal Testing
Non-invasive prenatal testing (NIPT), also known as cell-free DNA testing, is a prenatal 
screening tool used in the assessment of fetal chromosomal abnormalities. Cell-free DNA 
can be found in all individuals as a result of the natural turnover of cells. Small DNA 
fragments from this cellular turnover is found briefly in circulating blood plasma prior to 
being cleared. In pregnant mothers, a fraction of the small DNA fragments found in 
circulating plasma is from the outer trophoblastic cell layer of the placenta. These 
trophoblasts DNA fragments usually match the genotype of the developing fetus. A blood 
sample is drawn from the mother, then plasma concentrations of cell free DNA are divided 
into maternal and fetal fractions. This fetal fraction is compared to normal standards for the 
corresponding gestational age of the fetus. Individual chromosomes appear at known 
standard ratios within the fetal fraction. Ratios that deviate from the norm indicate an 
abnormality in that particular chromosome (Harraway, 2017).  WHO’s criteria for use of the 
test in listed in table 2.
Discussion
Klinefelter’s Syndrome carries with it a significant number of manageable symptoms and 
considerable comorbidities. With a larger number of men, up to 70-75%, going undiagnosed 
throughout their lifetime (Bojesen, 2003). Screening is needed to help in the diagnoses of 
the vast majority of these patients. With the technology of NIPT advancing and improving in 
its ability to detect a variety of other conditions outside of the traditional autosomal 
aneuploidy, it should be considered a technique for screening for clinically silent conditions, 
such as mild Klinefelter syndrome phonotypes. When a majority of patients are going 
undiagnosed and untreated the benefit of adding sex chromosomal aneuploidy to the test is 
two-fold. One if it allows for use to detect patients that would otherwise go undiagnosed 
until later in life, resulting in late introduction of testosterone replacement therapies, 
missing the critical stage of puberty. Second it allows us to improve our understanding of 
Klinefelter patients’ development during early childhood and the use of NIPT in prenatal 
diagnostics overall. 
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Clinical Consideration
Klinefelter Syndrome can present with any number of symptoms as indicated by table 1. It’s 
understood that these symptoms are attributed to several factors. 
• Number of genetic abnormalities (# of X, CAG repeats, PARs, & CNVs)
• Androgen dependent, Supernumerary X, or combined factors
• Age of presenting individual (symptoms worsen with age)
These features can be grouped by age of onset, androgen-dependence, supernumerary X-
dependence, or combined etiology (Bonomi, 2017). 
The neonate in question presents with no distinct, characteristic signs of Klinefelter Syndrome, 
which is common in many individuals. Due to the underwhelming and subtle nature of many 
Klinefelter phenotypes, a majority of patients go undiagnosed. Only two findings, other then the 
NIPT results, weakly suggest a possible abnormality.
• Respiratory distress seen in 9.2% of KS births as opposed to 1.2% in normal neonates (Dotters-
Katz, 2016). 
• Lower than normal birth weights for gestational age have been reported in KS neonates 
(Dotters-Katz, 2016), but as of this time, low birth weight alone does not give reason to 
suspect Klinefelter Syndrome. 
The underwhelming clinical presentation of the neonate shows that if NIPT wasn’t conducted, 
neither our patient nor his family would have known he was 47,XXY, until much later in life. Timely 
hormonal intervention is possible for our patient because of  NIPT. This demonstrates a need of a 
standard KS screen.  
World Health Organization’s Criteria for NIPT
The condition should be an important health problem
The natural history of the condition should be adequately
Facilities for diagnosis and treatment should be available
The overall benefit of screening should outweigh the harm
There should be scientific evidence regarding screening program 
effectiveness
The screening program should respond to a recognized need
The objectives of screening should be defined at the outset
Table 2, WHO’s criteria for non-invasive prenatal testing (Suciu, 2019)
